Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice

Over 20% of cancer patients will develop brain metastases. Prognosis is currently extremely poor, largely owing to late-stage diagnosis. We hypothesized that biofluid metabolomics could detect tumours at the micrometastatic stage, prior to the current clinical gold-standard of blood-brain barrier br...

Descripción completa

Detalles Bibliográficos
Autores principales: Larkin, James R., Dickens, Alex M., Claridge, Timothy D. W., Bristow, Claire, Andreou, Kleopatra, Anthony, Daniel C., Sibson, Nicola R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135440/
https://www.ncbi.nlm.nih.gov/pubmed/27924154
http://dx.doi.org/10.7150/thno.16538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135440/
https://www.ncbi.nlm.nih.gov/pubmed/27924154
http://dx.doi.org/10.7150/thno.16538

Ejemplares similares